Phase II study of erlotinib in patients with malignant pleural mesothelioma: A Southwest Oncology Group study

Linda L. Garland, Cathryn Rankin, David R Gandara, Saul E. Rivkin, Katherine M. Scott, Raymond B. Nagle, Andres J P Klein-Szanto, Joseph R. Testa, Deborah A. Altomare, Ernest C. Borden

Research output: Contribution to journalArticlepeer-review

185 Scopus citations

Fingerprint

Dive into the research topics of 'Phase II study of erlotinib in patients with malignant pleural mesothelioma: A Southwest Oncology Group study'. Together they form a unique fingerprint.

Medicine & Life Sciences